Neuralia TMS Provides Proven TMS Therapy to Help Manage Depression

Australia, 19th Nov 2025 – Neuralia TMS, a respected provider of neuromodulation treatments in Melbourne’s inner north, has reaffirmed its commitment to delivering evidence-supported Transcranial Magnetic Stimulation (TMS) therapy for individuals experiencing treatment-resistant depression. The clinic, located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC, continues to operate as a treatment centre offering structured, non-invasive therapeutic programs grounded in current clinical research.

TMS Therapy Overview Australia

TMS therapy has become a core component of modern mental health treatment in Australia. It offers an option for individuals for whom conventional interventions have not produced sufficient improvement. The technique uses externally applied magnetic pulses to stimulate specific brain regions involved in mood regulation. This non-invasive approach allows treatment without medication, anaesthesia, or surgical procedures, making it suitable for outpatient clinical settings such as Neuralia TMS.

The clinic’s treatment framework reflects the broader movement toward diversified therapeutic pathways. Depression is a complex condition influenced by biological and psychosocial factors. Treatment plans frequently combine multiple modalities. TMS therapy has increasingly integrated into multidisciplinary care, supported by research and clinical experience. Neuralia TMS applies this modality within a structured protocol to ensure safety, consistency, and adherence to established standards.

Dr Shanek Wick, Medical Director at Neuralia TMS, emphasized the clinical importance of regulated neuromodulation in the community. “TMS therapy at Neuralia TMS provides an evidence-supported method for addressing depressive symptoms when traditional treatments are limited,” Dr Wick stated. “Structured neuromodulation reflects mental health developments emphasizing targeted, measurable interventions.”

Structured Clinical Treatment Programs

Treatment programs at Neuralia TMS typically involve repeated sessions over several weeks. Each appointment is conducted by trained clinical staff familiar with TMS procedures. Session duration, treatment frequency, and stimulation parameters follow recognised guidelines, ensuring therapy aligns with contemporary clinical recommendations. Careful monitoring supports continuity and allows clinicians to track patient responses effectively.

In addition to TMS therapy, Neuralia TMS offers supplementary services that enhance treatment planning. Transcranial Direct Current Stimulation (tDCS) provides an at-home neuromodulation option for those needing structured support. The clinic also conducts pharmacogenetic testing to inform medication responsiveness based on genetic markers. These tools help clinicians build more precise treatment plans and serve as adjuncts to professional assessment.

The growth of neuromodulation in Australian mental health reflects rising interest in options beyond medication. Ongoing research explores TMS for conditions including anxiety disorders, PTSD, OCD, chronic pain, and neurological diseases such as Parkinson’s. Neuralia TMS aligns its protocols with current research and professional guidelines to maintain evidence-based treatment.

Future of Mental Health Treatment

Mental health treatment continues to evolve as technology and research advance. Depression remains a leading contributor to health-related disability, highlighting the need for diverse therapeutic options. TMS therapy is one component within broader treatment strategies, supporting individuals who require alternatives to conventional interventions.

Looking ahead, Dr Wick emphasized the importance of ongoing innovation. “Research in neuromodulation continues to advance, revealing new applications and refining existing methods,” he said. “These developments will enhance precision, expand accessibility, and strengthen integration of neuromodulation within mental health care.”

Regulated Neuromodulation Services

Neuralia TMS focuses on delivering regulated neuromodulation services aligned with contemporary evidence. Through continuous refinement of treatment protocols, engagement with research, and strong clinical oversight, the clinic aims to contribute meaningfully to Australia’s evolving mental health landscape. Their structured approach reflects broader efforts to improve outcomes for individuals experiencing depression and related conditions.

For further information about TMS for depression, Neuralia TMS can be contacted at 03 9122 5246 or via email at info@neuralia.com.au. The clinic is located at Suite 102/149-155 Pascoe Vale Rd, Moonee Ponds 3039 VIC.

Company Details

Organization: Neuralia TMS (Melbourne)

Contact Person: Dr Shanek Wick

Website: https://www.neuraliatms.com.au/

Email: Send Email

Contact Number: +61391225246

Address: 102/ 149-155 Pascoe Vale Rd

Address 2: Moonee Ponds Vic 3039

Country: Australia

Release Id: 19112537317